Female Sexual Dysfunction
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Female sexual dysfunction can drastically diminish quality of life for many women. It is estimated that in the United States 40% of women have sexual complaints. These conditions are frequently underdiagnosed and undertreated. Terminology and classification systems of female sexual dysfunction can be confusing and complicated, which hampers the process of clinical diagnosis, making accurate diagnosis difficult. There are few treatment options available for female sexual dysfunctions, however, some interventions may be of benefit and are described. Additional treatments are in development. The development of clear clinical categories and diagnostic guidelines for female sexual dysfunction are of utmost importance and can be of great benefit for clinical and public health uses and disease-related research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexual Dysfunction in the United States: Prevalence and Predictors
Laumann, E. O., Paik, A., & Rosen, R. C. (1999) · JAMA · doi:10.1001/jama.281.6.537 · Cited by 5,119
Development and evaluation of a scale to measure perceived self‐efficacy in people with arthritis
Lorig, K., Chastain, R. L., Ung, E., Shoor, S., & Holman, H. R. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320107 · Cited by 1,590
Sexual Problems and Distress in United States Women: Prevalence and Correlates
Shifren, J. L., Monz, B. U., Russo, P. A., Segreti, A., & Johannes, C. B. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181898cdb · Cited by 1,394
McCabe, M. P., Sharlip, I. D., Atalla, E., Balon, R., Fisher, A. D., Laumann, E., Lee, S. W., Lewis, R., & Segraves, R. T. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.019 · Cited by 605
Treatment-Emergent Sexual Dysfunction Related to Antidepressants: A Meta-Analysis
Serretti, A., & Chiesa, A. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a5233f · Cited by 583
Prevalence of Sexual Dysfunction Among Newer Antidepressants
Clayton, A. H., Pradko, J. F., Croft, H. A., Montano, C. B., Leadbetter, R. A., Bolden-Watson, C., Bass, K. I., Donahue, R. M. J., Jamerson, B. D., & Metz, A. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0414 · Cited by 542
Self-citationAtlantis, E., & Sullivan, T. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02709.x · Cited by 472
Reed, G. M., Drescher, J., Krueger, R. B., Atalla, E., Cochran, S. D., First, M. B., Cohen‐Kettenis, P. T., Arango‐de Montis, I., Parish, S. J., Cottler, S., et al. (2016) · World Psychiatry · doi:10.1002/wps.20354 · Cited by 469
First, M. B., Reed, G. M., Hyman, S. E., & Saxena, S. (2015) · World Psychiatry · doi:10.1002/wps.20189 · Cited by 366
Vulvodynia: Assessment and Treatment
Goldstein, A. T., Pukall, C. F., Brown, C., Bergeron, S., Stein, A., & Kellogg-Spadt, S. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.01.020 · Cited by 292
Research works printed but not linked: 73
- Wright, 2015, Female sexual dysfunction, Med Clin North Am, 99, 607, 10.1016/j.mcna.2015.01.011 · DOI
- Sungur, 2014, A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges, J Sex Med, 11, 364
- Sand, 2007, Women’s endorsement of models of female sexual response: the nurses’ sexuality study, J Sex Med, 4, 708
- Giles, 2009, Conceptualizing women’s sexual function: linear vs. circular models of sexual response, J Sex Med, 6, 2761
- Giraldi, 2015, Endorsement of models describing response of men and women with a sexual partner: an online survey in a population sample of Danish adults ages 20-65 years, J Sex Med, 12, 116
- Sarin, 2013, Disentangling desire and arousal: a classificatory conundrum, Arch Sex Behav, 42, 1079, 10.1007/s10508-013-0100-6 · DOI
- DeRogatis, 2011, Should sexual desire and arousal disorders in women be merged?, Arch Sex Behav, 40, 217, 10.1007/s10508-010-9677-1 · DOI
- Segraves, 2007, Proposal for changes in diagnostic criteria for sexual dysfunctions, J Sex Med, 4, 567
- Basson, 2001, Female sexual response: the role of drugs in the management of sexual dysfunction, Obstet Gynecol, 98, 350
- Hayes, 2006, What can prevalence studies tell us about female sexual difficulty and dysfunction?, J Sex Med, 3, 589
- Khajehei, 2015, An update on sexual function and dysfunction in women, Arch Womens Ment Health, 18, 423, 10.1007/s00737-015-0535-y · DOI
- Kingsberg, 2015, The female sexual response: current models, neurobiological underpinnings and agents currently approved or under investigation for the treatment of hypoactive sexual desire disorder, CNS Drugs, 29, 915, 10.1007/s40263-015-0288-1 · DOI
- Schultz, 1999, Magnetic resonance imaging of male and female genitals during coitus and female sexual arousal, BMJ, 319, 1596, 10.1136/bmj.319.7225.1596 · DOI · Paper page
- Nastri, 2013, Hormone therapy for sexual function in perimenopausal and postmenopausal women, Cochrane Database Syst Rev
- Shifren, 2006, Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study, Menopause, 13, 770, 10.1097/01.gme.0000227400.60816.52 · DOI · Paper page
- North American Menopause Society, 2005, The role of testosterone therapy in postmenopausal women: position statement of the North American Menopause Society, Menopause, 12, 496
- Davis, 2016, Androgens and female sexual function and dysfunction- findings from the fourth International Consultation of Sexual Medicine, J Sex Med, 13, 168
- Fooladi, 2012, An update on the pharmacological management of female sexual dysfunction, Expert Opin Pharmacother, 13, 2131, 10.1517/14656566.2012.725046 · DOI
- Goldstat, 2003, Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women, Menopause, 10, 390, 10.1097/01.GME.0000060256.03945.20 · DOI · Paper page
- Cayan, 2008, Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women, J Sex Med, 5, 132
- Wu, 2001, Quality of life and sexuality changes in postmenopausal women receiving tibolone therapy, Climacteric, 4, 314, 10.1080/cmt.4.4.314.319 · DOI
- Nijland, 2008, Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial, J Sex Med, 5, 646
- Constantine, 2015, Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial, Climacteric, 18, 226, 10.3109/13697137.2014.954996 · DOI · Paper page
- Portman, 2013, Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy, Menopause, 20, 623, 10.1097/gme.0b013e318279ba64 · DOI · Paper page
- Cui, 2014, Ospemifene, a novel selective estrogen receptor modulator for treating dyspareunia associated with postmenopausal vulvar and vaginal atrophy, J Sex Med, 11, 487
- Vallejos, 2016, Flibanserin: a novel, nonhormonal agent for the treatment of hypoactive sexual desire disorder in premenopausal women, J Pharm Pract
- Simon, 2014, Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial, Menopause, 21, 633, 10.1097/GME.0000000000000134 · DOI
- Gao, 2015, Efficacy and safety of flibanserin in women with hypoactive sexual desire disorder: a systematic review and meta-analysis, J Sex Med, 12, 2095
- Berman, 2003, Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study, J Urol, 170, 2333
- Basson, 2002, Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder, J Womens Health Gend Based Med, 11, 367, 10.1089/152460902317586001 · DOI · Paper page
- Caruso, 2001, Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study, BJOG, 108, 623
- Meston, 2008, Short- and long-term effects of Ginkgo biloba extract on sexual dysfunction in women, Arch Sex Behav, 37, 530, 10.1007/s10508-008-9316-2 · DOI
- Ito, 2006, The enhancement of female sexual function with ArginMax, a nutritional supplement, among women differing in menopausal status, J Sex Marital Ther, 32, 369, 10.1080/00926230600834901 · DOI
- Wilson, 2001, Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device, J Gend Specif Med, 4, 54
- Seagraves, 2004, Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women, J Clin Psychopharmacol, 24, 339, 10.1097/01.jcp.0000125686.20338.c1 · DOI · Paper page
- Kinsberg, 2013, Characterization of orgasmic difficulties by women: focus group evaluation, J Sex Med, 10, 2242
- Fisher, 1983, Patterns of female arousal during sleep and waking: vaginal thermoconductance studies, Arch Sex Behav, 12, 97, 10.1007/BF01541556 · DOI
- Wells, 1983, Nocturnal orgasms: females’ perception of a “normal” sexual experience, J Sex Res, 22, 412
- Komisaruk, 2005, Functional MRI of the brain during orgasm in women, Annu Rev Sex Res, 16, 62
- Dunn, 2005, Genetic influences on variation in female orgasmic function: a twin study, Biol Lett, 1, 260, 10.1098/rsbl.2005.0308 · DOI · Paper page
- Perlis, 2009, Genetic and clinical predictors of sexual dysfunction in citalopram-treated depressed patients, Neuropsychopharmacology, 34, 1819, 10.1038/npp.2009.4 · DOI · Paper page
- Braun, 2001, Socio-cultural representations of the vagina, J Reprod Infant Psychol, 18, 17, 10.1080/02646830020032374 · DOI · Paper page
- Schick, 2010, Genital appearance dissatisfaction: implications for women’s genital image self-consciousness, sexual esteem, sexual satisfaction, and sexual risk, Psychol Women Q, 34, 394, 10.1111/j.1471-6402.2010.01584.x · DOI · Paper page
- Birnbaum, 2003, The meaning of heterosexual intercourse among women with female orgasmic disorder, Arch Sex Behav, 32, 61, 10.1023/A:1021845513448 · DOI
- Burri, 2009, Emotional intelligence and its association with orgasmic frequency in women, J Sex Med, 6, 1930
- Rowland, 2016, Understanding orgasmic difficulty in women, J Sex Med, 13, 1246
- Redelman, 2006, A general look at female orgasm and anorgasmia, Sex Health, 3, 143, 10.1071/SH06005 · DOI
- Kamenov, 2007, Effect of tibolone on sexual function in late postmenopausal women, Folia Med (Plovdiv), 49, 41
- Jacques, 2010, Women’s sexual pain disorders, J Sex Med, 7, 616
- Simonelli, 2014, Female sexual pain disorders: dyspareunia and vaginismus, Curr Opin Psychiatry, 27, 406, 10.1097/YCO.0000000000000098 · DOI
- Cherner, 2013, A psychophysiological investigation of sexual arousal in women with lifelong vaginismus, J Sex Med, 42, 1605
- Melzack, 1975, The McGill Pain Questionnaire: major properties and scoring methods, Pain, 1, 277, 10.1016/0304-3959(75)90044-5 · DOI · Paper page
- Sullivan, 1995, The pain catastrophizing scale: development and validation, Psychol Assess, 7, 524, 10.1037/1040-3590.7.4.524 · doi:10.1037/1040-3590.7.4.524 · Paper page
- Hummel-Berry, 2007, Reliability and validity of the vulvar functional status questionnaire (VQ), J Womens Health Phys Therap, 31, 1605
- Friederich, 1987, Vulvar vestibulitis syndrome, J Reprod Med, 32, 110
- 2016, The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer, Obstet Gynecol, 127, e93, 10.1097/AOG.0000000000001351 · DOI · Paper page
- Bachmann, 2010, Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 study, Menopause, 17, 480, 10.1097/gme.0b013e3181c1ac01 · DOI · Paper page
- Leo, 2013, A systematic review of the utility of antidepressant pharmacotherapy in the treatment of vulvodynia pain, J Sex Med, 10, 2497
- Rosen, 2014, Impact of male partner responses on sexual function in women with vulvodynia and their partners - a dyadic daily experience study, Health Psychol, 33, 823, 10.1037/a0034550 · DOI · Paper page
- Melles, 2014, Automatic and deliberate affective associations with sexual stimuli in women with lifelong vaginismus before and after therapist aided exposure treatment, J Sex Med, 11, 786
- Ter Kuile, 2015, Therapist aided exposure for women with lifelong vaginismus: mediators of treatment outcome: a randomized waiting list control trial, J Sex Med, 12, 1807
- Melnik, 2012, Interventions for vaginismus, Cochrane Database Syst Rev
- Clayton, 2016, Sexual dysfunction due to psychotropic medications, Psychiatr Clin North Am, 39, 427, 10.1016/j.psc.2016.04.006 · DOI
- Clayton, 2006, Major depressive disorder, antidepressants, and sexual dysfunction, J Clin Psychiatry, 67, 33
- Taylor, 2013, Strategies for managing sexual dysfunction induced by antidepressant medication, Cochrane Database Syst Rev
- Landen, 1999, Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors, J Clin Psychopharmacol, 19, 268, 10.1097/00004714-199906000-00012 · DOI · Paper page
- Nunberg, 2008, Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial, JAMA, 300, 395, 10.1001/jama.300.4.395 · DOI · Paper page
- Lorenz, 2014, Exercise improves sexual function in women taking antidepressants: results from a randomized crossover trial, Depress Anxiety, 31, 188, 10.1002/da.22208 · DOI · Paper page
- Ozmenler, 2008, Mirtazapine augmentation in depressed patients with sexual dysfunction due to selective serotonin reuptake inhibitors, Hum Psychopharmacol, 23, 321, 10.1002/hup.929 · DOI · Paper page
- Clayton, 2007, Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder, J Sex Med, 4, 917, 10.1111/j.1743-6109.2007.00520.x · DOI · Paper page
- Clayton, 2006, Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies, J Clin Psychiatry, 67, 736, 10.4088/JCP.v67n0507 · DOI · Paper page
- Thase, 2006, A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability, J Clin Psychopharmacology, 26, 482, 10.1097/01.jcp.0000239790.83707.ab · DOI · Paper page
- Kennedy, 2006, Sexual function during bupropion or paroxetine treatment of major depressive disorder, Can J Psychiatry, 51, 234, 10.1177/070674370605100405 · DOI · Paper page
Cited by
Clinical practice guidelines for the care of girls and women with Turner syndrome.
Gravholt, C. H., Andersen, N. H., Christin-Maitre, S., Davis, S. M., Duijnhouwer, A., Gawlik, A., Maciel-Guerra, A. T., Gutmark-Little, I., Fleischer, K., Hong, D., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae050 · Cited by 224
Association of mindfulness with female sexual dysfunction
Sood, R., Kuhle, C. L., Thielen, J. M., Kapoor, E., Vencill, J. A., Mara, K. C., & Faubion, S. S. (2022) · Maturitas · doi:10.1016/j.maturitas.2022.02.002 · Cited by 15
Metadata
- Authors
- Clayton, A. H., & Valladares Juarez, E. M.
- Venue
- Medical Clinics of North America
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 103
- Issue
- 4
- Pages
- 681-698
- ISSN
- 0025-7125 (ISSN-L)
- OpenAlex
- W2943900897
- Cited by
- 158
- References
- 14
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Endoceutics, Inc.
- Janssen
- Sage Therapeutics
- Takeda
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.